| Security | Market Valueª | Shares or Principal | Investment
Discretion | Other
Managersº | Voting Authority |
|---|
| Issuer Name | Issue Class | Opt. | CUSIP/CINS | $1000s | Weight | Amount | S/P | Price | Sole | Shared | None |
|---|
 | | | | | | | | | ↓List | (S/P Amounts or For All) |
|---|
|
| ADMA BIOLOGICS INC | COM | – | 000899·10·4 | 13,675 | 20.55% | 3,608,171 | Sh. | 3.79 | Sole | – | Sole | – | – |
| AIMMUNE THERAPEUTICS INC. | COM | – | 00900T·10·7 | 44,477 | 66.84% | 1,990,000 | Sh. | 22.35 | Sole | – | Sole | – | – |
| CIDARA THERAPEUTICS INC. | COM | – | 171757·10·7 | 2,706 | 4.07% | 1,021,148 | Sh. | 2.65 | Sole | – | Sole | – | – |
| TRANSENTERIX INC. | COM NEW | – | 89366M·20·1 | 5,687 | 8.55% | 2,389,352 | Sh. | 2.38 | Sole | – | Sole | – | – |
| — 4 Issuers — | — 4 Issues — | — 4 Holdings: $66,545,000 — | — Sole Manager — |
____________
ª No market value of any Holding was adjusted.
º Other Included Managers with whom investment discretion is shared as to any Holding: No Other Included Managers |
|
